Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PNGBE Doing DD tonite, hope to place a nice bid in AM, also plan on acquiring some AEBF
AEBF Check out this sweet lil play.
Scuse me if this is a repeat!
BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable, drug-free anti-inflammatory devices, today announced it has reached an agreement with SAY-GIN Ozel Egtim Yayincilik Ticaret Hizmetleri (SAY-GIN) for distribution of its ActiPatch and Allay products in Turkey.
SAY-GIN has already committed to orders totaling more than $1 million USD in 2010. SAY-GIN is launching a direct response television campaign in Turkey to support sales of both the ActiPatch and Allay product lines.
“We are very excited about expanding into Turkey and are looking forward to working with SAY-GIN,” said BioElectronics Vice President Sales and Marketing, Arnon Horev. “Turkey has the 15th largest gross domestic product, putting it in the same neighborhood as Canada (14th) and Mexico (11th), and entering this gateway market is important accomplishment for our international expansion.
“With SAY-GIN’s commitment to orders in 2010, it is clear that their consumers are highly receptive to our drug-free pain relieving and healing technology and we believe that will continue to be true as we expand into new markets and build our international presence. We will continue to aggressively move into international markets, with major initiatives already underway in Latin America, China, Japan and Europe. Our partnership with SAY-GIN will help to ensure our international efforts continue to be successful.”
I'm on the sidelines as of now. Would like to see a pullback to below $12.00. I think we will see this price again this year.
I use Zecco for all of my pinkies and more recently anything I want to trade, not invest in. The problem is getting money to them, which takes a couple of days. Stock that I want to invest in, I use a larger online broker.
I just need any good pr. I'm outta here at .12, i really dont need this company to be huge. Im just in it for the trade. But I do think this stock does have a shot. seems like a good niche product. But I would be shocked if BIEL ever hits .25 even if it gets approval.
Good morning friends!
Bash it if you want, I'm in it for the trade.
Feb 13, 2010 11:21 ET
Healthy Coffee Chinese New Year PromotionNEWPORT BEACH, CA--(Marketwire - February 13, 2010)
- Healthy Coffee International, Inc. (PINKSHEETS: HCEI) announced today that the company will have a Chinese New Year promotion in celebration of the Chinese New Year and the Healthy Coffee joint venture with HYNG of China.
The products included in this promotion are the EnerGi Blend instant gourmet coffee with cream and cane sugar; EnerGi Black instant gourmet black coffee; EnerGi Chai instant milk tea; and EnerGi Blast instant energy drink. All products have ginseng extract which is known to provide energy and reishi (lingzhi) extract which is known to increase the immune system and improve circulation.
"The promotion is effective immediately and lasts until February 28, 2010. We have setup a toll free hotline for this promo: 800-373-7051. We want HCEI shareholders to taste the delicious Healthy Coffee products by enabling them to purchase its products at wholesale distributor prices. And if they are interested in the business opportunity, we will refer them to the independent distributor closest to them" commented Mr. Rick Aguiluz, architect of the Healthy Coffee concept and CEO of Healthy Coffee International.
ABOUT HEALTHY COFFEE INTERNATIONAL, INC.
Healthy Coffee International, Inc., category creator of Healthy Coffee, is focused on bringing health to the world's largest and most popular drink, coffee. The company's proprietary formulas combine the health benefits of Ginseng, Reishi Mushroom, and other top quality ingredients with the world's finest coffee beans to create a line of deliciously healthy instant gourmet coffee drinks. Healthy Coffee is well positioned in the market place at the intersection of three mega-billion dollar industries: coffee, wellness and energy drinks, and has quickly established offices in11 countries and distributors in 29 other countries through its marketing subsidiary Healthy Coffee USA, Inc. (www.HealthyCoffee.com) which uses a simple and unique Internet-driven international business model that allows the average person to own and operate a local, national, or international coffee distribution or coffee house business with very little capital investment or overhead. For more information, visit www.HCEI.biz
Feb 13, 2010 11:21 ET
Healthy Coffee Chinese New Year PromotionNEWPORT BEACH, CA--(Marketwire - February 13, 2010)
- Healthy Coffee International, Inc. (PINKSHEETS: HCEI) announced today that the company will have a Chinese New Year promotion in celebration of the Chinese New Year and the Healthy Coffee joint venture with HYNG of China.
The products included in this promotion are the EnerGi Blend instant gourmet coffee with cream and cane sugar; EnerGi Black instant gourmet black coffee; EnerGi Chai instant milk tea; and EnerGi Blast instant energy drink. All products have ginseng extract which is known to provide energy and reishi (lingzhi) extract which is known to increase the immune system and improve circulation.
"The promotion is effective immediately and lasts until February 28, 2010. We have setup a toll free hotline for this promo: 800-373-7051. We want HCEI shareholders to taste the delicious Healthy Coffee products by enabling them to purchase its products at wholesale distributor prices. And if they are interested in the business opportunity, we will refer them to the independent distributor closest to them" commented Mr. Rick Aguiluz, architect of the Healthy Coffee concept and CEO of Healthy Coffee International.
ABOUT HEALTHY COFFEE INTERNATIONAL, INC.
Healthy Coffee International, Inc., category creator of Healthy Coffee, is focused on bringing health to the world's largest and most popular drink, coffee. The company's proprietary formulas combine the health benefits of Ginseng, Reishi Mushroom, and other top quality ingredients with the world's finest coffee beans to create a line of deliciously healthy instant gourmet coffee drinks. Healthy Coffee is well positioned in the market place at the intersection of three mega-billion dollar industries: coffee, wellness and energy drinks, and has quickly established offices in11 countries and distributors in 29 other countries through its marketing subsidiary Healthy Coffee USA, Inc. (www.HealthyCoffee.com) which uses a simple and unique Internet-driven international business model that allows the average person to own and operate a local, national, or international coffee distribution or coffee house business with very little capital investment or overhead. For more information, visit www.HCEI.biz
Averaged down HCEI once again. In at .90, .23, and now .15. at least I'm not staring at that .90 anymore
Averaged down HCEI once again. In at .90, .23, and now .15. at least I'm not staring at that .90 anymore.
All as I want is $1.82 in 2010 and my sell goes through. Thats my target. It will make me a bundle. No sense waiting for a dream.
Zecco post orders as rejected or accepted. then you wait for it to be filled. Didnt say restricted.
I tried all day to buy at Zecco. Rejected 3 times at a limit and rejected 2 times at market. Go figure! I wanted to avg down on BIEL, but they wouldnt let me.
Good Morning Chart & WU.
Bought more HCEI at .23. First batch at .90, I really needed to avg. down.
First we have earnings bump,
then we have Super Bowl Ad bumps,
then we have buy out bump,
2.00 by March, hopefully.
New Press Release
Press Release
YesDTC Acquires Japanese Distribution Rights For ActiPatch Therapy
Posted on: Wed, 27 Jan 2010 12:27:22 EST
Symbols: BIEL, YESD
Are you looking to increase your ETF knowledge?
See the PowerRating of BIEL,YESD now and learn how it rates on a 1-10 scale.The higher the PowerRating, the greater potential short-term gain based on historical data.
Jan 27, 2010 (FinancialWire via COMTEX) --
(Comment on this article at http://www.financialwire.net/2010/01/27/yesdtc-acquires-japanese-distribution-rights-for-actipatch-therapy/)
January 27, 2010 (FinancialWire) -- YesDTC Holdings, Inc. (OTCBB: YESD | Quote | Chart | News | PowerRating), a direct-to-consumer global distributor and marketer of consumer goods and products, announces the company has successfully completed negotiations with BioElectronics, Corp. (OTC: BIEL | Quote | Chart | News | PowerRating) to begin distribution of the award-winning ActiPatch(TM) Therapy disposable drug-free anti-inflammatory device throughout Japan.
Under the terms of the arrangement, YesDTC will hold full television, direct-to-consumer and retail distribution rights to consumers within the world's second largest economy. YesDTC plans to initially launch distribution through direct response television advertising and is currently formulating plans for retail launch. ActiPatch is currently categorized within Japan as a Class I medical device.
YesDTC Holdings, Inc. is a direct-to-consumer marketing company specializing in direct response television, Internet and retail marketing programs.
FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network's "FirstAlert(tm) Daily" (http://www.financialwire.net/news-alerts/).
FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.
http://www.financialwire.net
For full details on (BIEL) BIEL. (BIEL) has Short Term PowerRatings at TradingMarkets. Details on (BIEL) Short Term PowerRatings is available at This Link.
For full details on (YESD) YESD. (YESD) has Short Term PowerRatings at TradingMarkets. Details on (YESD) Short Term PowerRatings is available at This Link.
Good Morning Chart and all of WU!!!
Monies, do you have your eye on this run. Cant find any news as to why, but I'll soon be at my break even. But as of now, dont plan on selling until I see how 2010 pans out.
Riding TIBB on a nice little 2 day run. If this keeps up, I'll break even, lol.
Nice run today, up 42%. Couldnt find any news on why the jump.
WAG on May 4th 2010 midday
Good Morning Chart and WU!!
I dont think TIBB will be profitable until the housing market in FL stabilizes. I dont think we will see that in 2010. Hopefully early 2011. but I do think this bank will come roaring back and that is why I am still a shareholder.
Good Morning Chart and WU!
Happy New Year to all of Wealth University!!!!
Good morning Chart and WU!!!
My thoughts are with you today Chart. We are all so very sad for you. Prayers have been with you every step of the way.
Life really sucks sometimes.
HCEI info,
If you go to a alibaba.com(a global trading site)and type in Healthy Coffee, you will find our infamous coffee. About half way down the page you can see a picture of Black Coffee (EnerGI) in the brown envelope
This will give you a supplier (Watsula Consultants Limited) from the United Kingdom.
When I searched on this site a month or so ago, I could not find anything. Hopefully this is good news.
Catcher's mitt on Chart, and I'm calling for a fast ball, but most of the pitchers on my team only throw change ups.
DCGN up 150%, But I'm in at .58. Long way to go for me.
DCGN now up 154% at .23. Bad news is that I'm in at .58.
Up 100% DCGN - deCODE
deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin
A Single SNP That Confers Increased Risk if Inherited From the Father, but is Protective if Inherited From the Mother
REYKJAVIK, Iceland, December 16 /PRNewswire-FirstCall/
-- Scientists at deCODE genetics, Inc. (Nasdaq:DCGN) publish in the journal Nature the discovery of a version of a common single-letter variant in the sequence of the human genome (SNP) with a major impact on susceptibility to type 2 diabetes (T2D). The impact of the T2D variant is not only large, but unusual: if an individual inherits it from their father, the variant increases risk of T2D by more than 30% compared to those who inherit the non T2D-linked version; if inherited maternally, the variant lowers risk by more than 10% compared to the non T2D-linked version. Nearly one quarter of those studied have the highest risk combination of the versions of this SNP, putting them at a roughly 50% greater lifetime risk of T2D than the quarter with the protective combination. This is the second largest effect of any genetic variant for T2D apart from SNPs in TCF7L2, discovered by deCODE in 2006.
"We could make this discovery beacause we are in the unique position of being able to distinguish what is inherited from the mother from what is inherited from the father. This we can do because of the large amount of data we have assembled on the Icelandic population. These data empower us in many ways. For example, using our ability to impute sequence data, we can multiply by 100 times the amount of information generated by sequencing one individual. We can use these tools to discover and integrate rarer variants into our tests and scans, identify drug targets for licensing, and put our know-how at the disposal of our service customers. We believe that this is an important advantage for conducting large-scale whole sequence studies over the next couple of years," said Kari Stefansson, CEO of deCODE.
Because the risk is inherited and varies in this way, the SNP, located on chromsome 11, had never been linked to T2D even though it had been genotyped in large, traditional genome-wide association studies (GWAS). These do not distinguish between paternally and maternally inherited SNPs. But deCODE can track the parental origin of virtually any SNP in the genome of the tens of thousands of Icelandic participants in the company's gene discovery work. In this study, deCODE used its population-wide genealogy database and proprietary statistical tools to determine the parent of origin of a number of SNPs in some 40,000 Icelandic participants in the company's gene discovery programs. Some of these SNPs had previously been associated with different diseases and are located near "imprinted" genes - genes in which only the maternally or paternally inherited copy is "switched-on" to encode a protein. Five of these, one each in breast and skin cancer and three in T2D, showed that the parental origin of the variants affects the risk they confer.
The paper, "Parental origin of sequence variants associated with complex diseases," is published online at http://www.nature.com, and will appear in the December 17 print edition.
deCODE Discovers a Major Risk Factor for Type 2 Diabetes
Dependent on Parent of Origin
A Single SNP That Confers Increased Risk if Inherited From the Father, but is Protective if Inherited From the Mother
REYKJAVIK, Iceland, December 16 /PRNewswire-FirstCall/ -- Scientists at deCODE genetics, Inc. (Nasdaq:DCGN) publish in the journal Nature the discovery of a version of a common single-letter variant in the sequence of the human genome (SNP) with a major impact on susceptibility to type 2 diabetes (T2D). The impact of the T2D variant is not only large, but unusual: if an individual inherits it from their father, the variant increases risk of T2D by more than 30% compared to those who inherit the non T2D-linked version; if inherited maternally, the variant lowers risk by more than 10% compared to the non T2D-linked version. Nearly one quarter of those studied have the highest risk combination of the versions of this SNP, putting them at a roughly 50% greater lifetime risk of T2D than the quarter with the protective combination. This is the second largest effect of any genetic variant for T2D apart from SNPs in TCF7L2, discovered by deCODE in 2006.
"We could make this discovery beacause we are in the unique position of being able to distinguish what is inherited from the mother from what is inherited from the father. This we can do because of the large amount of data we have assembled on the Icelandic population. These data empower us in many ways. For example, using our ability to impute sequence data, we can multiply by 100 times the amount of information generated by sequencing one individual. We can use these tools to discover and integrate rarer variants into our tests and scans, identify drug targets for licensing, and put our know-how at the disposal of our service customers. We believe that this is an important advantage for conducting large-scale whole sequence studies over the next couple of years," said Kari Stefansson, CEO of deCODE.
Because the risk is inherited and varies in this way, the SNP, located on chromsome 11, had never been linked to T2D even though it had been genotyped in large, traditional genome-wide association studies (GWAS). These do not distinguish between paternally and maternally inherited SNPs. But deCODE can track the parental origin of virtually any SNP in the genome of the tens of thousands of Icelandic participants in the company's gene discovery work. In this study, deCODE used its population-wide genealogy database and proprietary statistical tools to determine the parent of origin of a number of SNPs in some 40,000 Icelandic participants in the company's gene discovery programs. Some of these SNPs had previously been associated with different diseases and are located near "imprinted" genes - genes in which only the maternally or paternally inherited copy is "switched-on" to encode a protein. Five of these, one each in breast and skin cancer and three in T2D, showed that the parental origin of the variants affects the risk they confer.
The paper, "Parental origin of sequence variants associated with complex diseases," is published online at http://www.nature.com, and will appear in the December 17 print edition.
This stock will come back, they(most) all do. Im in at .09 but i'll avg down and next time somebody pumps this stock and it goes up a little, i'm outta here. And I'll remove it from my favs and never check on it again.
I doubt if I do, but I hope. I got in at .90 WOW, bought at the top.
Doublediamond, had that on cut and paste and you beat me to it, lol